Volumetric analysis of the periodontal microstructure under antiresorptive therapy: an experimental study in rabbits
- PMID: 35449246
- DOI: 10.1007/s00784-022-04503-z
Volumetric analysis of the periodontal microstructure under antiresorptive therapy: an experimental study in rabbits
Abstract
Objectives: The objective of this study was to volumetrically assess changes in the periodontal microstructure under antiresorptive therapy.
Materials and methods: Microtomographic scans from a total of 9 Dutch Belted rabbits having been randomly allocated to either the intravenous administration of amino-bisphosphonate (zoledronic acid) (Za) (n = 5) or a negative control group (nZa) (n = 4) were obtained at 10 months following a repeated drug administration. A quantification of the periodontal space thickness (P.Th) of both maxillary and mandibular most posterior premolars, as well as of the 2nd molars was performed. Bone micromorphometry was assessed by means of bone volume per total volume (BV/TV), the bone mineral density (BMD), trabecular thickness (Tb.Th), trabecular number (Tb.N), bone surface (BS), and the specific bone surface (BS/BV).
Results: Za was associated with significantly higher P.Th (P = 0.010), which was most pronounced in the upper jaw. Bone micromorphometry revealed no significant differences among the two groups, i.e., Za and nZa, for all the investigated parameters.
Conclusions: Volumetric analysis revealed that antiresorptive therapy was associated with periodontal space widening, whereas major effects on the bone micro-morphology could not be observed.
Clinical relevance: A deep understanding of specific periodontal and alveolar bone alterations in patients under antiresorptive therapy might help to prevent the onset of medication-related osteonecrosis of the jaw.
Keywords: Micro-CT analysis; Periodontal ligament; Preclinical study; Zoledronic acid.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Similar articles
-
Influence of ridge preservation procedures on extraction socket healing under antiresorptive therapy: An experimental study in rabbits.Clin Implant Dent Relat Res. 2020 Aug;22(4):477-485. doi: 10.1111/cid.12916. Epub 2020 Jun 15. Clin Implant Dent Relat Res. 2020. PMID: 32537909
-
Early bony changes associated with bisphosphonate-related osteonecrosis of the jaws in rats: A longitudinal in vivo study.Arch Oral Biol. 2017 Oct;82:79-85. doi: 10.1016/j.archoralbio.2017.06.002. Epub 2017 Jun 6. Arch Oral Biol. 2017. PMID: 28622548
-
Microarchitecture of medication-related osteonecrosis of the jaw (MRONJ); a retrospective micro-CT and morphometric analysis.J Craniomaxillofac Surg. 2021 Jun;49(6):508-517. doi: 10.1016/j.jcms.2021.02.018. Epub 2021 Mar 2. J Craniomaxillofac Surg. 2021. PMID: 33707134
-
Rheumatoid Arthritis Exacerbates the Severity of Osteonecrosis of the Jaws (ONJ) in Mice. A Randomized, Prospective, Controlled Animal Study.J Bone Miner Res. 2016 Aug;31(8):1596-607. doi: 10.1002/jbmr.2827. Epub 2016 May 4. J Bone Miner Res. 2016. PMID: 26950411 Free PMC article.
-
Abnormal subchondral bone microstructure following steroid administration is involved in the early pathogenesis of steroid-induced osteonecrosis.Osteoporos Int. 2016 Jan;27(1):153-9. doi: 10.1007/s00198-015-3225-8. Epub 2015 Jul 9. Osteoporos Int. 2016. PMID: 26156290
Cited by
-
Comparison of quantitative radiomorphometric predictors of healthy and MRONJ-affected bone using panoramic radiography and cone-beam CT.Dentomaxillofac Radiol. 2024 Sep 1;53(6):407-416. doi: 10.1093/dmfr/twae024. Dentomaxillofac Radiol. 2024. PMID: 38810135 Free PMC article.
-
Influence of antiresorptive/antiangiogenic therapy on the extension of experimentally induced peri-implantitis lesions.Clin Oral Investig. 2023 Jun;27(6):3009-3019. doi: 10.1007/s00784-023-04904-8. Epub 2023 Feb 17. Clin Oral Investig. 2023. PMID: 36800025 Free PMC article.
-
Influence of antiresorptive/antiangiogenic therapy on changes in periodontal and oral tissue structures: a histomorphometrical analysis in rats.Clin Oral Investig. 2023 Dec;27(12):7695-7704. doi: 10.1007/s00784-023-05359-7. Epub 2023 Nov 1. Clin Oral Investig. 2023. PMID: 37910240 Free PMC article.
References
-
- Barry E, Taylor T, Patel J, Hamid U, Bryant C (2021) The incidence of medication-related osteonecrosis of the jaw following tooth extraction in patients prescribed oral bisphosphonates. Br Dent J. https://doi.org/10.1038/s41415-021-3620-9 - DOI - PubMed
-
- Wick A, Bankosegger P, Otto S, Hohlweg-Majert B, Steiner T, Probst F, Ristow O, Pautke C (2021) Risk factors associated with onset of medication-related osteonecrosis of the jaw in patients treated with denosumab. Clin Oral Investig. https://doi.org/10.1007/s00784-021-04261-4 - DOI - PubMed - PMC
-
- Ramaglia L, Guida A, Iorio-Siciliano V, Cuozzo A, Blasi A, Sculean A (2018) Stage-specific therapeutic strategies of medication-related osteonecrosis of the jaws: a systematic review and meta-analysis of the drug suspension protocol. Clin Oral Investig 22:597–615. https://doi.org/10.1007/s00784-017-2325-6 - DOI - PubMed
-
- Alsalih A, Dam A, Lindberg P, Truedsson A (2021) Medication-related osteonecrosis of the jaws initiated by zoledronic acid and potential pathophysiology. Dent J (Basel) 9:85. https://doi.org/10.3390/dj9080085 - DOI
-
- Beth-Tasdogan NH, Mayer B, Hussein H, Zolk O (2017) Interventions for managing medication-related osteonecrosis of the jaw. Cochrane Database Syst Rev 10:Cd012432. https://doi.org/10.1002/14651858.CD012432.pub2 - DOI - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical